Adagio Medical Holdings, Inc Common Stock (ADGM) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Adagio Medical Holdings, Inc Common Stock stock (ADGM) is currently trading at $1.26. Adagio Medical Holdings, Inc Common Stock PS ratio (Price-to-Sales) is 174.69. Analyst consensus price target for ADGM is $4.00. WallStSmart rates ADGM as Sell.
- ADGM PE ratio analysis and historical PE chart
- ADGM PS ratio (Price-to-Sales) history and trend
- ADGM intrinsic value — DCF, Graham Number, EPV models
- ADGM stock price prediction 2025 2026 2027 2028 2029 2030
- ADGM fair value vs current price
- ADGM insider transactions and insider buying
- Is ADGM undervalued or overvalued?
- Adagio Medical Holdings, Inc Common Stock financial analysis — revenue, earnings, cash flow
- ADGM Piotroski F-Score and Altman Z-Score
- ADGM analyst price target and Smart Rating
Adagio Medical Holdings, Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Adagio Medical Holdings, Inc Common Stock (ADGM) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book, revenue growth, institutional own.. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Adagio Medical Holdings, Inc Common Stock (ADGM) Key Strengths (3)
Revenue surging 75.60% year-over-year
80.05% of shares held by major funds and institutions
Trading at 1.88x book value, attractively priced
Supporting Valuation Data
Adagio Medical Holdings, Inc Common Stock (ADGM) Areas to Watch (4)
Company is destroying shareholder value
Losing money on operations
Very expensive at 174.7x annual revenue
Micro-cap company with very limited liquidity and high volatility
Supporting Valuation Data
Adagio Medical Holdings, Inc Common Stock (ADGM) Detailed Analysis Report
Overall Assessment
This company scores 32/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 3 register as strengths (avg 9.3/10) while 4 fall into concern territory (avg 1.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Revenue Growth, Institutional Own., Price/Book. Valuation metrics including Price/Book (1.88) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 75.60%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Price/Sales. Some valuation metrics including Price/Sales (174.69) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -210.40%, Operating Margin at -19544.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -210.40% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 75.60% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ADGM Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ADGM's Price-to-Sales ratio of 174.69x trades at a 32% premium to its historical average of 132.8x (80th percentile). The current valuation is 52% below its historical high of 363.58x set in Aug 2024, and 177% above its historical low of 63.15x in Nov 2025. Over the past 12 months, the PS ratio has expanded from ~74.0x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for Adagio Medical Holdings, Inc Common Stock (ADGM) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Adagio Medical Holdings, Inc Common Stock is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 137,000 with 76% growth year-over-year.
Key Findings
Revenue growing at 76% YoY, reaching 137,000. This pace significantly outperforms most MEDICAL DEVICES peers.
Debt-to-equity ratio of -16.74 indicates a conservative balance sheet with 5M in cash.
Free cash flow is -4M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can Adagio Medical Holdings, Inc Common Stock maintain 76%+ revenue growth, or will competition slow it down?
Debt management: total debt of 22M is significantly higher than cash (5M). Monitor refinancing risk.
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Adagio Medical Holdings, Inc Common Stock.
Bottom Line
Adagio Medical Holdings, Inc Common Stock is a high-conviction growth story with revenue accelerating at 76% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin 0.0% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Adagio Medical Holdings, Inc Common Stock(ADGM)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
Adagio Medical Holdings, Inc. is a pioneering biotech firm specializing in advanced medical technologies tailored for the treatment of cardiac arrhythmias. Through its proprietary platform, the company is innovating targeted ablation techniques that address critical needs within the electrophysiology market. With a robust product pipeline and a seasoned leadership team, Adagio presents an attractive opportunity for institutional investors aiming to engage in the evolving landscape of healthcare innovation and improve patient outcomes in the cardiac sector.